Vincent Cheung
Clinical Research Fellow
Description of research
PRedicting and preventing Immunotherapy Side Effects (PRISE) study
Recent publications
-
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Journal article
Cheung VTF. et al, (2020), British Journal of Cancer, 123, 207 - 215
-
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.
Journal article
Dagens A. et al, (2020), BMJ (Clinical research ed.), 369
-
Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
Conference paper
Cheung VTF. et al, (2020), JOURNAL OF CROHNS & COLITIS, 14, S286 - S288
-
Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis
Conference paper
Sasson SC. et al, (2019), ANNALS OF ONCOLOGY, 30, 530 - 530
-
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
Journal article
CHEUNG VINCENT. et al, (2019), Frontline Gastroenterology